<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac magnetic resonance imaging (MRI) has a central role in the management of patients with <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cardiac MRIs help to identify patients with risk for life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Delayed enhancement identifies scar tissue within the heart </plain></SENT>
<SENT sid="3" pm="."><plain>Because scar harbors the arrhythmic substrate in patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, areas of delayed enhancement can be targeted in order to eliminate <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> with catheter ablation procedures </plain></SENT>
<SENT sid="4" pm="."><plain>In this article, we will discuss the role of MRI in diagnosing different forms of non-ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and its role in risk stratification </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, we will discuss the role of MRI in imaging of the arrhythmogenic substrate in patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
</text></document>